Point72 Middle East FZE »

Adicet Bio shares owned by Point72 Middle East FZE

Quarter-by-quarter ownership of Adicet Bio (ACET) shares owned by Point72 Middle East FZE from 13F filings

Historical chart of Point72 Middle East FZE investment in Adicet Bio

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio held by Point72 Middle East FZE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio by Point72 Middle East FZE

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.7k 4.6k 1.89
2023-09-30 $16k 11k 1.37
2023-03-31 $55k 9.6k 5.76
2022-12-31 $110k 12k 8.94

More positions owned by Point72 Middle East FZE

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
General Motors Company (GM)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Caterpillar Call Option (CAT)
UnitedHealth (UNH)
Amazon (AMZN)
Jd.com Spon Adr Cl A (JD)
Lauder Estee Cos Cl A Call Option (EL)
Target Corporation Call Option (TGT)
At&t (T)
Analog Devices Call Option (ADI)
Synopsys (SNPS)

View all positions for Point72 Middle East FZE

Top funds holding Adicet Bio

OrbiMed Advisors
Cowen And Company
Carlyle
Vanguard Group
Millennium Management
Tang Capital Management
Two Sigma Advisers
Norges Bank Investment Management
Two Sigma Investments
D. E. Shaw & Co
Schonfeld Strategic Advisors
Dimensional Fund Advisors
Citadel Advisors
Bank of New York Mellon
Exchange Traded Concepts

View all funds holding Adicet Bio